Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00970684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

Nathan Pennell, MD, PhD

Collaborators

[object Object]